AUTHOREA
Log in Sign Up Browse Preprints

loading page

Tofacitinib plus iguratimod for improving rheumatoid arthritis-related usual interstitial pneumonia: a three-case report and literature review
  • +1
  • Shuhua Wang,
  • Yao Li,
  • Yanchun Tang,
  • Weilin Xie
Shuhua Wang
Qindao University Medical College Affiliated Yantai Yuhuangding Hospital

Corresponding Author:[email protected]

Author Profile
Yao Li
Qindao University Medical College Affiliated Yantai Yuhuangding Hospital
Author Profile
Yanchun Tang
Qindao University Medical College Affiliated Yantai Yuhuangding Hospital
Author Profile
Weilin Xie
Qindao University Medical College Affiliated Yantai Yuhuangding Hospital
Author Profile

Abstract

RA-UIP has a poor prognosis, and how to reverse or stabilize the lesions remains challenging. Based on researches finding that tofacitinib and IGU might be effective in pulmonary fibrosis, we present 3 cases that treated with the combined strategy with significant improvement of DAS28-CRP score and reversals in HRCT.

Peer review status:IN REVISION

25 Aug 2022Submitted to Clinical Case Reports
Show details
Hide details
30 Aug 2022Submission Checks Completed
30 Aug 2022Assigned to Editor
03 Sep 2022Reviewer(s) Assigned
26 Sep 2022Review(s) Completed, Editorial Evaluation Pending
27 Sep 2022Editorial Decision: Revise Minor